These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8523398)

  • 21. Discovery of 2-azetidinone and 1H-pyrrole-2,5-dione derivatives containing sulfonamide group at the side chain as potential cholesterol absorption inhibitors.
    Yuan X; Lu P; Xue X; Qin H; Fan C; Wang Y; Zhang Q
    Bioorg Med Chem Lett; 2016 Feb; 26(3):849-853. PubMed ID: 26783178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agents.
    Magnin DR; Biller SA; Wetterau J; Robl JA; Dickson JK; Taunk P; Harrity TW; Lawrence RM; Sun CQ; Wang T; Logan J; Fryszman O; Connolly F; Jolibois K; Kunselman L
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1337-40. PubMed ID: 12657277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Evaluation of 2-Azetidinone and 1H-Pyrrole-2,5-dione Derivatives as Cholesterol Absorption Inhibitors for Reducing Inflammation Response and Oxidative Stress.
    Xia Y; Zhu L; Yuan X; Wang Y
    Chem Biodivers; 2019 Feb; 16(2):e1800189. PubMed ID: 30230227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterocyclic ring scaffolds as small-molecule cholesterol absorption inhibitors.
    Ritter T; Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Biomol Chem; 2005 Oct; 3(19):3514-23. PubMed ID: 16172689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.
    Goel RK; Thind JS; Bal CS; Mahajan MP; Kulkarni SK
    Pharmazie; 2005 May; 60(5):369-74. PubMed ID: 15918588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ezetimibe. Schering-Plough.
    Meng CQ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):427-32. PubMed ID: 12054091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The discovery of ezetimibe: a view from outside the receptor.
    Clader JW
    J Med Chem; 2004 Jan; 47(1):1-9. PubMed ID: 14695813
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbohydrate sulfonyl chlorides for simple, convenient access to glycoconjugates.
    Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Lett; 2005 Mar; 7(6):1145-8. PubMed ID: 15760160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery, synthesis and evaluation of novel cholesterol absorption inhibitors.
    Zhu X; Ji J; Huang D; Zhu Y; Tang C; Yang X; Qian H; Huang W
    Chem Biol Drug Des; 2012 Sep; 80(3):426-33. PubMed ID: 22642541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles.
    Labonté ED; Howles PN; Granholm NA; Rojas JC; Davies JP; Ioannou YA; Hui DY
    Biochim Biophys Acta; 2007 Sep; 1771(9):1132-9. PubMed ID: 17442616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.
    Howell KL; DeVita RJ; Garcia-Calvo M; Meurer RD; Lisnock J; Bull HG; McMasters DR; McCann ME; Mills SG
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6929-32. PubMed ID: 21030254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter.
    Kramer W; Glombik H; Petry S; Heuer H; Schäfer H; Wendler W; Corsiero D; Girbig F; Weyland C
    FEBS Lett; 2000 Dec; 487(2):293-7. PubMed ID: 11150527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute inhibition of lymphatic cholesterol transport in rat intestine by SCH 58053.
    Hayashi H; Kanai S; Yamada Y; Tsushima M; Miyasaka K
    J Atheroscler Thromb; 2006 Oct; 13(5):240-6. PubMed ID: 17146152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
    Sutton JC; Bolton SA; Davis ME; Hartl KS; Jacobson B; Mathur A; Ogletree ML; Slusarchyk WA; Zahler R; Seiler SM; Bisacchi GS
    Bioorg Med Chem Lett; 2004 May; 14(9):2233-9. PubMed ID: 15081015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors.
    Abu Khalaf R; Sabbah D; Al-Shalabi E; Bishtawi S; Albadawi G; Abu Sheikha G
    Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29112287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease.
    Parsy C; Alexandre FR; Brandt G; Caillet C; Cappelle S; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4444-4449. PubMed ID: 25155387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.
    Han Y; Han M; Shin D; Song C; Hahn HG
    J Med Chem; 2012 Sep; 55(18):8188-92. PubMed ID: 22938049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.